CONSCIENCIA 38
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Asociación entre deterioro cognitivo, depresión y ansiedad
Referencias
Bermúdez, B. P., Sánchez, R. A. y Turrent, C. A. (2016).
Evaluación del daño crónico en pacientes con síndrome
antifosfolípidos con el instrumento Damage Index
in Antiphospholipid Syndrome (DIAPS). An Med (Mex),
61, 177-181.
Cervera, R. (2017). Antiphospholipid syndrome. Thrombosis
Research, 151(suppl), S43-S47.
McLaurin, E. Y., Holliday, S. L. y Williams, P. (2005). Predictors
of cognitive dysfunction in patients with systemic
lupus erythematosus. Neurology, 64, 297-303.
Miyakis, S., Lockshin, M. D. y Atsumi, T. (2006). International
consensus statement on an update of the classification
criteria for definite antiphospholipid syndrome
(APS). J Thromb Haemost, 4, 295-306.
Chaturvedi, S. y McCraeb, K. R. (2017). Diagnosis and
management of the antiphospholipid syndrome. Blood
Rev, 31, 406-417.
Coín, M. A., Vilar, L. R. y Peralta, R. I. (2015). The role
of antiphospholipid autoantibodies in the cognitive deficits
of patients with systemic lupus erythematosus.
LupusI, 24, 875-879.
Montiel, A.; Vásquez, J.; Hernández, C., Augusto, C. y
Martínez, J. (2018). La calidad de vida y depresión de
pacientes con lupus eritematoso sistémico, Vertientes,
217-220.
Olazarán, J., Hoyos, A. M. y Del Ser, T. (2016). Aplicación
práctica de los test cognitivos breves. Neurología,
31, 183-194.
Erkan, D., Barbhaiya, M. y George, D. (2010). Moderate
versus high-titer persistently anticardiolipin antibody
positive patients: Are they clinically different and does
high-titer anti-b2-glycoprotein-I antibody positivity
offer additional predictive information? Lupus, 19, 613-
619.
Jacobson, M. W., Rapport, L. J. y Keenan, P. A. (1999).
Neuropsychological Deficits Associated with Antiphospholipid
Antibodies. J Clin Exp Neuropsychol, 21, 251-264.
Kozora, E., Erkan, D. y Zhang, L. (2014). Cognitive dysfunction
in antiphospholipid antibody (aPL)-negative
systemic lupus erythematosus (SLE) versus aPL-positive
non-SLE patients. Clin Exp Rheumatol, 32, 34-40.
Petersen, R. C., Roberts, R. O. y Knopman, D. S. (2009).
Mild cognitive impairment: ten years later. Arch Neurol,
66, 1447-1455.
Sciascia, S., Amigo, M. C. y Roccatello, D. (2017). Diagnosing
antiphospholipid syndrome: ‘extra-criteria’ manifestations
and technical advances. Nat Rev Rheumatol,
13, 548-560.
Tektonidou, M. G., Varsou. N. y Kotoulas, G. (2006).
Cognitive deficits in patients with antiphospholipid
syndrome. Association with clinical, laboratory, and
brain magnetic resonance imaging findings. Arch Intern
Med, 166, 2278-84.
50 Revista ConSciencia de la Escuela de Psicología